CAS: 1110767-45-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | (E)-3-(2,6-Dichloro-4-((4-(3-(2,2-dimethyl-1-propoxypropyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylic acid REF: IN-DA0294D6CAS: 1110767-45-7 | 99% | A consultar | Mar 10 Dic 24 |
 | Butyzamide REF: TM-T67894CAS: 1110767-45-7 | 100% - 99% | 266,00 €~2.499,00 € | Lun 27 Ene 25 |
(E)-3-(2,6-Dichloro-4-((4-(3-(2,2-dimethyl-1-propoxypropyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylic acid
CAS:1110767-45-7
Fórmula:
C29H32Cl2N2O5S
Pureza:
99%
Forma y color:
Solid
Peso molecular:
591.5458
Ref: IN-DA0294D6
| 1mg | 516,00 € | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Butyzamide
CAS:1110767-45-7
Butyzamide: oral Mpl activator, non-peptide, antagonizes TPO receptors, boosts hMpl, Ba/F3 cells, and enhances platelets …
Fórmula:
C29H32Cl2N2O5S
Pureza:
100% - 99%
Forma y color:
Soild
Peso molecular:
591.55
Ref: TM-T67894
| 1mg | 266,00 € | ||
| 5mg | 638,00 € | ||
| 10mg | 927,00 € | ||
| 25mg | 1.375,00 € | ||
| 50mg | 1.849,00 € | ||
| 100mg | 2.499,00 € |
Entrega estimada en Estados Unidos, el Lunes 27 de Enero de 2025
